Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2015 - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/2lqlm7/partnerships) has announced the addition of the "Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2015" mergers & acquisitions to their offering.

The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q4 2015.

The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Reasons to buy:

  • Enhance your decision making capability in a more rapid and time sensitive manner.
  • Find out the major deal performing segments for investments in your industry.
  • Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
  • Identify companies that are aggressively looking to raise capital in the market
  • Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
  • Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
  • Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
  • Identify growth segments and opportunities in each region within the industry.
  • Look for key financial advisers where you are planning to raise capital from the market or for acquisitions within the industry.

Key Topics Covered:

1 List of Tables & Figures

2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q4 2015

3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type

4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2015

5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q4 2015

6 Pharmaceuticals & Healthcare, Global, M&A Financial Analysis

7 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area

8 Deal Summary by Geography

9 Pharmaceuticals & Healthcare, Global, Top Advisors

10 Appendix

11 Further Information

For more information visit http://www.researchandmarkets.com/research/2lqlm7/partnerships

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Company Reports

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Company Reports